Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-05-19 @ 12:42 PM
Study NCT ID:
NCT05176002
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-19
First Post:
2021-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Sponsor:
Organization: